The NanoBusiness Alliance Responds To New Report, “Regulating the Products of Nanotechnology: Does FDA Have The Tools It Needs?”

CHICAGO--(BUSINESS WIRE)--The NanoBusiness Alliance released its commentary today on The Project on Emerging Nanotechnologies (PEN) FDA Report authored by former Food and Drug Administration (FDA) Deputy Commissioner for Policy Michael R. Taylor. The report claims that gaps in legal authority and insufficient resources hinder the FDA’s efforts to better understand and manage the potential risks from hundreds of new products incorporating nanotechnologies.